Advertisement

Sarcomas of the Temporal Bone

  • Jamie A. Ku
  • Paul W. Gidley
  • Erich M. Sturgis
Chapter

Abstract

Temporal bone sarcomas represent a heterogeneous group of rare malignancies. Optimal treatment of temporal bone sarcoma is challenging and necessitates a multidisciplinary approach with surgery, chemotherapy, and radiotherapy. This chapter discusses the etiology, diagnosis, evaluation, staging, treatment, and prognosis of temporal bone sarcomas. It also introduces the most common types of temporal bone sarcoma.

Keywords

Sarcoma Temporal bone Head and neck Surgery Radiation Chemotherapy 

References

  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.Google Scholar
  2. 2.
    Potter BO, Sturgis EM. Sarcomas of the head and neck. Surg Oncol Clin N Am. 2003;12(2):379–417.PubMedGoogle Scholar
  3. 3.
    Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumours of soft tissue and bone. Surg Oncol Clin N Am. 2016;25(4):621–43.PubMedGoogle Scholar
  4. 4.
    Hui JY. Epidemiology and Etiology of sarcomas. Surg Clin North Am. 2016;96(5):901–14.PubMedGoogle Scholar
  5. 5.
    Shellenberger TD, Sturgis EM. Sarcomas of the head and neck region. Curr Oncol Rep. 2009;11(2):135–42.PubMedGoogle Scholar
  6. 6.
    Huh WW, Fitzgerald N, Mahajan A, Sturgis EM, Beverly Raney R, Anderson PM. Pediatric sarcomas and related tumors of the head and neck. Cancer Treat Rev. 2011;37(6):431–9.PubMedGoogle Scholar
  7. 7.
    Peng KA, Grogan T, Wang MB. Head and neck sarcomas: analysis of the SEER database. Otolaryngol Head Neck Surg. 2014;151(4):627–33.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Monroe MM, Guadagnolo BA, Ravi V, Wang W, Sturgis EM. Sarcomas and soft tissue tumors of the head and neck. In: Myers JN, Hanna EYN, Myers EN, editors. Cancer of the head and neck. 5th ed. Philadelphia: Wolters Kluwer; 2017.Google Scholar
  9. 9.
    Leonetti JP, Marzo SJ. Malignancy of the temporal bone. Otolaryngol Clin North Am. 2002;35(2):405–10.PubMedGoogle Scholar
  10. 10.
    Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH. Predictors of survival and recurrence after temporal bone resection for cancer. Head Neck. 2012;34(9):1231–9.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Gidley PW, DeMonte F. Temporal bone malignancies. Neurosurg Clin N Am. 2013;24(1):97–110.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Hahn SS, Kim JA, Goodchild N, Constable WC. Carcinoma of the middle ear and external auditory canal. Int J Radiat Oncol Biol. 1983;9(7):1003–7.Google Scholar
  13. 13.
    Gloria-Cruz TI, Schachern PA, Paparella MM, Adams GL, Fulton SE. Metastases to temporal bones from primary nonsystemic malignant neoplasms. Arch Otolaryngol Head Neck Surg. 2000;126(2):209–14.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Gidley PW, Thompson CR, Roberts DB, DeMonte F, Hanna EY. The oncology of otology. Laryngoscope. 2012;122(2):393–400.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Hizli O, Salduz A, Kaya S, Paparella MM, Cureoglu S. A rare location for sarcoma metastasis: the temporal bone. Am J Otolaryngol. 2015;36(6):772–7.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Scholsem M, Raket D, Flandroy P, Sciot R, Deprez M. Primary temporal bone angiosarcoma: a case report. J Neurooncol. 2005;75(2):121–5.PubMedGoogle Scholar
  17. 17.
    Al-Daraji W, Lasota J, Foss R, Miettinen M. Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions. Am J Surg Pathol. 2009;33(10):1494–503.PubMedGoogle Scholar
  18. 18.
    Cross JP Jr, Ladaga LA. Peripheral synovial sarcoma metastatic to the temporal bone. Am J Otol. 1986;7(3):169–71.PubMedGoogle Scholar
  19. 19.
    Hsieh ST, Guo YC, Tsai TL, Li WY, Lin CZ. Parosteal osteosarcoma of the mastoid bone following radiotherapy for nasopharyngeal carcinoma. J Chin Med Assoc. 2004;67(6):314–6.PubMedGoogle Scholar
  20. 20.
    Sharma SC, Handa KK, Panda N, Banerjee AK, Mann SB. Osteogenic sarcoma of the temporal bone. Am J Otolaryngol. 1997;18(3):220–3.PubMedGoogle Scholar
  21. 21.
    Seo T, Nagareda T, Shimano K, Saka N, Kashiba K, Mori T, et al. Liposarcoma of temporal bone: a case report. Auris Nasus Larynx. 2007;34(4):511–3.PubMedGoogle Scholar
  22. 22.
    Agarwal PN, Mishra SD, Pratap VK. Primary liposarcoma of the mastoid. J Laryngol Otol. 1975;89(10):1079–82.PubMedGoogle Scholar
  23. 23.
    Coatesworth AP, Martin-Hirsch DP, MacDonald A. Post-irradiation liposarcoma of the temporal bone. J Laryngol Otol. 1996;110(8):779–81.PubMedGoogle Scholar
  24. 24.
    Charlton CA, Leiomyosarcoma of the external auditory canal. Br J Surg. 1964;51:24–5.PubMedGoogle Scholar
  25. 25.
    Rasp G, Holtmann S, Wiebecke B. Leiomyosarcoma of the external ear canal. Laryngorhinootologie. 1991;70(3):164–6.PubMedGoogle Scholar
  26. 26.
    Lambert EM, Gunn GB, Gidley PW. Effects of radiation on the temporal bone in patients with head and neck cancer. Head Neck. 2016;38(9):1428–35.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Goh YH, Chong VF, Low WK. Temporal bone tumours in patients irradiated for nasopharyngeal neoplasm. J Laryngol Otol. 1999;113(3):222–8.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Lambert EM, Garden AS, DeMonte F, Roberts DB, Gidley PW. Radiation-associated malignancies of the ear canal and temporal bone. Laryngoscope. 2015;125(5):1198–204.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol. 2000;1(3):258–61.PubMedGoogle Scholar
  30. 30.
    Lustig LR, Jackler RK, Lanser MJ. Radiation-induced tumors of the temporal bone. Am J Otol. 1997;18(2):230–5.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Nakanishi H, Tomita Y, Myoui A, Yoshikawa H, Sakai K, Kato Y, et al. Mutation of the p53 gene in postradiation sarcoma. Lab Invest. 1998;78(6):727–33.PubMedGoogle Scholar
  32. 32.
    Pisters PW, Weiss M, Maki RG, Raut CP. Soft-tissue sarcomas. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 291–6.Google Scholar
  33. 33.
    Shuman AG, Brennan MF, Palmer FL, Kuk D, Moraco N, Singer S, et al. Soft tissue sarcoma of the head & neck: nomogram validation and analysis of staging systems. J Surg Oncol. 2015;111(6):690–5.PubMedPubMedCentralGoogle Scholar
  34. 34.
    O’Sullivan B, Maki RG, Agulnik M, Patel SG, Lazar AJ, Jones RL, et al. Soft tissue sarcoma of the head and neck. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC cancer staging manual. 8th ed. Switzerland: Springer; 2017. p. 499–505.Google Scholar
  35. 35.
    Coffin CM, Davis JL, Borinstein SC. Syndrome-associated soft tissue tumours. Histopathology. 2014;64(1):68–87.Google Scholar
  36. 36.
    Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg. 2011;145(6):967–73.Google Scholar
  37. 37.
    Reilly BK, Kim A, Pena MT, Dong TA, Rossi C, Murnick JG, et al. Rhabdomyosarcoma of the head and neck in children: review and update. Int J Pediatr Otorhinolaryngol. 2015;79(9):1477–83.Google Scholar
  38. 38.
    Durve DV, Kanegaonkar RG, Albert D, Levitt G. Paediatric rhabdomyosarcoma of the ear and temporal bone. Clin Otolaryngol Allied Sci. 2004;29(1):32–7.Google Scholar
  39. 39.
    Sbeity S, Abella A, Arcand P, Quintal MC, Saliba I. Temporal bone rhabdomyosarcoma in children. Int J Pediatr Otorhinolaryngol. 2007;71(5):807–14.Google Scholar
  40. 40.
    Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children’s oncology group (COG) soft-tissue sarcoma committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59(1):5–10.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Gluth MB. Rhabdomyosarcoma and other pediatric temporal bone malignancies. Otolaryngol Clin North Am. 2015;48(2):375–90.Google Scholar
  42. 42.
    Jaffe BF, Fox JE, Batsakis JG. Rhabdomyosarcoma of the middle ear and mastoid. Cancer. 1971;27(1):29–37.PubMedGoogle Scholar
  43. 43.
    Raney RB Jr, Lawrence W Jr, Maurer HM, Lindberg RD, Newton WA Jr, Ragab AH, et al. Rhabdomyosarcoma of the ear in childhood. A report from the Intergroup Rhabdomyosarcoma Study—I. Cancer. 1983;51(12):2356–61.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Le Deley MC, Delattre O, Schaefer KL, Burchill SA, Koehler G, Hogendoorn PC, et al. Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(12):1982–8.Google Scholar
  45. 45.
    Hoglund M, Gisselsson D, Mandahl N, Mitelman F. Ewing tumours and synovial sarcomas have critical features of karyotype evolution in common with epithelial tumours. Int J Cancer. 2005;116(3):401–6.PubMedGoogle Scholar
  46. 46.
    Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol. 2008;20(4):412–8.PubMedGoogle Scholar
  47. 47.
    Allam A, El-Husseiny G, Khafaga Y, Kandil A, Gray A, Ezzat A, et al. Ewing’s sarcoma of the head and neck: a retrospective analysis of 24 cases. Sarcoma. 1999;3(1):11–5.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Siegal GP, Oliver WR, Reinus WR, Gilula LA, Foulkes MA, Kissane JM, et al. Primary Ewing’s sarcoma involving the bones of the head and neck. Cancer. 1987;60(11):2829–40.PubMedGoogle Scholar
  49. 49.
    Kadar AA, Hearst MJ, Collins MH, Mangano FT, Samy RN. Ewing’s sarcoma of the petrous temporal bone: case report and literature review. Skull Base. 2010;20(3):213–7.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Hara N, Kaneko H, Inoue K, Watanabe M. Primary Ewing’s sarcoma of the temporal bone—case report (author’s transl). No Shinkei Geka Neurol Surg. 1980;8(6):557–62.Google Scholar
  51. 51.
    Davidson MJ. Ewing’s sarcoma of the temporal bone. A case report. Oral Surg Oral Med Oral Pathol. 1991;72(5):534–6.PubMedGoogle Scholar
  52. 52.
    Watanabe H, Tsubokawa T, Katayama Y, Koyama S, Nakamura S. Primary Ewing’s sarcoma of the temporal bone. Surg Neurol. 1992;37(1):54–8.PubMedGoogle Scholar
  53. 53.
    Kuzeyli K, Akturk F, Reis A, Cakir E, Baykal S, Pekince A, et al. Primary Ewing’s sarcoma of the temporal bone with intracranial, extracranial and intraorbital extension. Case report. Neurosurg Rev. 1997;20(2):132–4.PubMedGoogle Scholar
  54. 54.
    Desai K, Goel A, Nadkarni TD. Primary petrous bone Ewing’s sarcoma. Br J Neurosurg. 2000;14(2):143–5.PubMedGoogle Scholar
  55. 55.
    Souviron Encabo R, Arenas Britez O, Gil R, Perez-Luengo E, Scola Yurrita B. Primitive neuroectodermal tumor/extraosseus Ewing sarcoma of the temporal bone. Acta Otorrinolaringol Esp. 2005;56(1):38–40.Google Scholar
  56. 56.
    Nandi M, Bhattacharya J, Goswami S, Goswami C. Primary Ewing’s sarcoma of the squamous part of temporal bone in a young girl treated with adjuvant volumetric arc therapy. J Cancer Res Ther. 2015;11(4):1015–7.PubMedGoogle Scholar
  57. 57.
    Whaley JT, Indelicato DJ, Morris CG, Hinerman RW, Amdur RJ, Mendenhall WM, et al. Ewing tumors of the head and neck. Am J Clin Oncol. 2010;33(4):321–6.PubMedGoogle Scholar
  58. 58.
    Carroll R, Miketic LM. Ewing sarcoma of the temporal bone: CT appearance. J Comput Assist Tomogr. 1987;11(2):362–3.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Raney RB, Asmar L, Newton WA Jr, Bagwell C, Breneman JC, Crist W, et al. Ewing’s sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(2):574–82.Google Scholar
  60. 60.
    Grevener K, Haveman LM, Ranft A, van den Berg H, Jung S, Ladenstein R, et al. Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer. 2016;63(4):604–10.PubMedGoogle Scholar
  61. 61.
    Moore DD, Luu HH. Osteosarcoma. Cancer Treat Res. 2014;162:65–92.PubMedGoogle Scholar
  62. 62.
    Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115(7):1531–43.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A. 1985;82(18):6216–20.PubMedPubMedCentralGoogle Scholar
  64. 64.
    Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 2007;26(1):1–18.PubMedGoogle Scholar
  65. 65.
    Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002;70(6):1582–8.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Smith RB, Apostolakis LW, Karnell LH, Koch BB, Robinson RA, Zhen W, et al. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer. 2003;98(8):1670–80.PubMedGoogle Scholar
  67. 67.
    Kassir RR, Rassekh CH, Kinsella JB, Segas J, Carrau RL, Hokanson JA. Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope. 1997;107(1):56–61.PubMedGoogle Scholar
  68. 68.
    Laskar S, Basu A, Muckaden MA, D’Cruz A, Pai S, Jambhekar N, et al. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck. 2008;30(8):1020–6.PubMedGoogle Scholar
  69. 69.
    Ha PK, Eisele DW, Frassica FJ, Zahurak ML, McCarthy EF. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope. 1999;109(6):964–9.PubMedGoogle Scholar
  70. 70.
    Mark RJ, Sercarz JA, Tran L, Dodd LG, Selch M, Calcaterra TC. Osteogenic sarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg. 1991;117(7):761–6.PubMedGoogle Scholar
  71. 71.
    Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009;115(14):3262–70.PubMedGoogle Scholar
  72. 72.
    Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002;95(7):1495–503.PubMedGoogle Scholar
  73. 73.
    Rand CW. Osteosarcoma of left temporal bone followed by development of an astrocytoma of underlying temporal lobe. Thirty year review of an unusual case. Bull Los Angel Neuro Soc. 1961;26:23–31.PubMedGoogle Scholar
  74. 74.
    Gertner R, Podoshin L, Fradis M. Osteogenic sarcoma of the temporal bone. J Laryngol Otol. 1983;97(7):627–31.PubMedGoogle Scholar
  75. 75.
    Sataloff RT, Myers DL, Spiegel JR, Roberts BR, Telian S. Total temporal bone resection for osteogenic sarcoma. Ear Nose Throat J. 1988;67(9):626–7, 30–2, 34 passim.PubMedGoogle Scholar
  76. 76.
    Kellie SJ, Hutchison RE, Robertson JT, Pratt CB. Successful treatment of a radiation-associated extradural osteosarcoma with chemotherapy in an adolescent girl. Med Pediatr Oncol. 1989;17(6):514–9.PubMedGoogle Scholar
  77. 77.
    Iemoto Y, Ushigome S, Ikegami M, Koide K. Case report 648: Parosteal osteosarcoma arising from the right temporal bone. Skelet Radiol. 1991;20(1):59–61.Google Scholar
  78. 78.
    Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(1):363–7.Google Scholar
  79. 79.
    Daw NC, Mahmoud HH, Meyer WH, Jenkins JJ, Kaste SC, Poquette CA, et al. Bone sarcomas of the head and neck in children: the St Jude Children’s research hospital experience. Cancer. 2000;88(9):2172–80.PubMedGoogle Scholar
  80. 80.
    Leddy LR, Holmes RE. Chondrosarcoma of bone. Cancer Treat Res. 2014;162:117–30.PubMedGoogle Scholar
  81. 81.
    Barnes R, Catto M. Chondrosarcoma of bone. J Bone Joint Surg. 1966;48(4):729–64.Google Scholar
  82. 82.
    Verdegaal SH, Bovee JV, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771–9.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2(1):14.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Ruark DS, Schlehaider UK, Shah JP. Chondrosarcomas of the head and neck. World J Surg. 1992;16(5):1010–5. discussion 5-6.PubMedGoogle Scholar
  85. 85.
    Burkey BB, Hoffman HT, Baker SR, Thornton AF, McClatchey KD. Chondrosarcoma of the head and neck. Laryngoscope. 1990;100(12):1301–5.PubMedGoogle Scholar
  86. 86.
    Ellis MA, Gerry DR, Byrd JK. Head and neck chondrosarcomas: analysis of the Surveillance, Epidemiology, and End Results database. Head Neck. 2016;38(9):1359–66.PubMedGoogle Scholar
  87. 87.
    Koch BB, Karnell LH, Hoffman HT, Apostolakis LW, Robinson RA, Zhen W, et al. National cancer database report on chondrosarcoma of the head and neck. Head Neck. 2000;22(4):408–25.PubMedGoogle Scholar
  88. 88.
    Lustig LR, Sciubba J, Holliday MJ. Chondrosarcomas of the skull base and temporal bone. J Laryngol Otol. 2007;121(8):725–35.PubMedGoogle Scholar
  89. 89.
    Yagisawa M, Ishitoya J, Tsukuda M, Sakagami M. Chondrosarcoma of the temporal bone. Auris Nasus Larynx. 2007;34(4):527–31.PubMedGoogle Scholar
  90. 90.
    Raghu M, Moumoulidis I, De R, Moffat D. Chondrosarcomas of the temporal bone: presentation and management. J Laryngol Otol. 2004;118(7):551–5.PubMedGoogle Scholar
  91. 91.
    Tao D, Hoffman MR, Chen B. Temporal bone chondrosarcoma: presentation of 4 cases and review of the literature. Ear Nose Throat J. 2014;93(12):494–500.PubMedGoogle Scholar
  92. 92.
    Coltrera MD, Googe PB, Harrist TJ, Hyams VJ, Schiller AL, Goodman ML. Chondrosarcoma of the temporal bone. Diagnosis and treatment of 13 cases and review of the literature. Cancer. 1986;58(12):2689–96.PubMedGoogle Scholar
  93. 93.
    Aneiros-Fernandez J, Antonio Retamero J, Husein-Elahmed H, Ovalle F, Aneiros-Cachaza J. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors. Eur J Dermatol. 2016;26(1):9–12.PubMedGoogle Scholar
  94. 94.
    Wanebo HJ, Koness RJ, MacFarlane JK, Eilber FR, Byers RM, Elias EG, et al. Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck. 1992;14(1):1–7.PubMedGoogle Scholar
  95. 95.
    Farhood AI, Hajdu SI, Shiu MH, Strong EW. Soft tissue sarcomas of the head and neck in adults. Am J Surg. 1990;160(4):365–9.PubMedGoogle Scholar
  96. 96.
    Freedman AM, Reiman HM, Woods JE. Soft-tissue sarcomas of the head and neck. Am J Surg. 1989;158(4):367–72.PubMedGoogle Scholar
  97. 97.
    Eloy JA, Mortensen M, Gupta S, Lewis MS, Brett EM, Genden EM. Metastasis of uterine leiomyosarcoma to the thyroid gland: case report and review of the literature. Thyroid. 2007;17(12):1295–7.PubMedGoogle Scholar
  98. 98.
    Cassoni A, Terenzi V, Bartoli D, Zadeh OR, Battisti A, Pagnoni M, et al. Metastatic uterine leiomyosarcoma in the upper buccal gingiva misdiagnosed as an epulis. Case Rep Oncol Med. 2014;2014:402342.PubMedPubMedCentralGoogle Scholar
  99. 99.
    Tomasini D, Niccoli A, Crivelli F, Scandroglio I. Cutaneous scalp metastasis as the first indication of a clinically silent retroperitoneal leiomyosarcoma and of its further relapse as metastatic widespread disease. Eur J Dermatol. 2014;24(2):264–5.PubMedGoogle Scholar
  100. 100.
    Nusrath MA, Kendall CH, Avery CM. Metastatic uterine leiomyosarcoma masquerading as a primary lesion of the masseter muscle. Int J Oral Maxillofac Surg. 2006;35(5):466–8.PubMedGoogle Scholar
  101. 101.
    Vora NM, Levin RJ. Metastatic leiomyosarcoma to the tongue. Otolaryngol Head Neck Surg. 2003;128(4):601–2.PubMedGoogle Scholar
  102. 102.
    Annest NM, Grekin SJ, Stone MS, Messingham MJ. Cutaneous leiomyosarcoma: a tumor of the head and neck. Dermatol Surg. 2007;33(5):628–33.PubMedGoogle Scholar
  103. 103.
    Yadav J, Bakshi J, Chouhan M, Modi R. Head and neck leiomyosarcoma. Ind J Otolaryngol Head Neck Surg. 2013;65(Suppl 1):1–5.Google Scholar
  104. 104.
    Eppsteiner RW, DeYoung BR, Milhem MM, Pagedar NA. Leiomyosarcoma of the head and neck: a population-based analysis. Arch Otolaryngol Head Neck Surg. 2011;137(9):921–4.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Zbaren P, Ruchti C. Leiomyosarcoma of the middle ear and temporal bone. Ann Otol Rhinol Laryngol. 1994;103(7):537–41.PubMedGoogle Scholar
  106. 106.
    Ursick JA, Linthicum FH. Leiomyosarcoma of the temporal bone. Otol Neurotol. 2011;32(4):e30–1.PubMedGoogle Scholar
  107. 107.
    Kim BG, Kim J, Lee WS. Leiomyosarcoma of the middle ear and temporal bone. Clin Exp Otorhinolaryngol. 2013;6(4):254–8.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Nilles R, Plinkert PK, Ruck P. Leiomyosarcoma of the temporal bone. Laryngorhinootologie. 1995;74(1):54–6.PubMedGoogle Scholar
  109. 109.
    Izumi K, Maeda T, Cheng J, Saku T. Primary leiomyosarcoma of the maxilla with regional lymph node metastasis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80(3):310–9.PubMedGoogle Scholar
  110. 110.
    Farshid G, Pradhan M, Goldblum J, Weiss SW. Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol. 2002;26(1):14–24.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jamie A. Ku
    • 1
  • Paul W. Gidley
    • 2
  • Erich M. Sturgis
    • 2
    • 3
    • 4
  1. 1.Cleveland Clinic Head and Neck InstituteClevelandUSA
  2. 2.Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  3. 3.Department of EpidemiologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  4. 4.Christopher and Susan Damico Chair in Viral Associated MalignanciesThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations